• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1996 Fiscal Year Final Research Report Summary

Etiology, pathopysiology and treatment of NK cell-lineage leukemias and lymphomas

Research Project

Project/Area Number 07457234
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionJuntendo University School of Medicine

Principal Investigator

OSHIMI Kazuo  Juntendo University School of Medicine, Professor, 医学部, 教授 (40089991)

Project Period (FY) 1995 – 1996
KeywordsNK cell / EB virus / MDR1
Research Abstract

1. Infection of Epstein-Barr virus (EBV) in NK cells.
From the studies of cases of NK cell disorders, EBV was considered to be the etiologic agentin aggressive-type NK-GLPD and NK-cell lymphomas. In indolent-type NK-GLPD,however, EBV seemed to be unrelated to the disorder.
2. Characterization of NK cells in various types of NK-cell disorders.
NK cells obtained from patients with various types of NK-cell disorders were studied in terms of surface phenotype, cell lineage, developmental stage, cytotoxicity, and T-cell receptor (TCR) and IgH genes. In nasal NK-cell lymphoma, malignant NK cells seemed to be activated mature NK cells, but not to be immature NK cells. In NK-GLPD,it is uncertain whether NK cells of aggressive-type NK-GLPD are immature cell sor activated mature NK cells, and NK cells of indolent-type NK-GLPD were found to be activated mature NK cells.
3. Expression of multidrug resistance (MDR) 1-coded P-glycoprotein (P-gp) on NK cells
NK cells including normal NK cells, nasal NK lymphoma cells, aggressive type NK-GLPD cells, indolent-type NK-GLPD cells, and two NK-cell lines were tested fortheir expression of P-gp. Except one NK-cell line, all the NK cells tested were found to express P-gp. Further, the function of P-gp was inhibited by the addition of cyclosporin A and its derivative PSC833. Because of these in vitro study of these drugs on P-gp function, their in vivo function must be delineated.
4. Transformation of NK cells with EBV
In vitro transformation of NK cells with EBV has been tried. A preliminary study indicates the possible infection of EBV into normal NK cells and a NK cell line. Now the finding is being confirmed by other techniques.

  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] Kaneko T et al.: "Nasel naturel killer(NK)cell lymphoma……" Br J Haematol. 91. 353-361 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Oshimi Y et al.: "Necrosin and apoptosis associated with……" J Physiol. 495.2. 319-329 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Oshimi K: "Lymphoproliferative disorders of natural……" Int J Hematol. 63. 279-290 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Semenzato G et al.: "The lymphoprobiferative disease of……" Blood. 63. 256-260 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kaneko T,Fukuda J,Yoshihara T,Zheng H,Mori S,Mizoguchi H,Oshimi K: "Nasal natural killer (NK) cell lymphoma : report of a case with activated NK cells containing Ep stein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells." Br J Haematol. 91. 161-355 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oshimi Y,Oshimi K,Miyazaki S: "Necrosis and apoptosis associated with distinct Ca2+ response patterns in target cells attacked by human natural killer cells." J Physiol. 495.2. 319-329 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oshimi K: "Lymphoprolif erative disorders of natural killer cells." Int J Hematol. 63. 279-290 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Semenzato G,Zambello R,Starkebaum G,Oshimi K,Loughran TP: "The lymphoprolif erative disorders of granular lymphocytes : updated criteria for diagnosis." Blood. 89. 256-260 (1997)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi